- Gestational Diabetes Research and Management
- Pregnancy and preeclampsia studies
- Gastrointestinal motility and disorders
- Acute Kidney Injury Research
- Cardiac, Anesthesia and Surgical Outcomes
- Congenital gastrointestinal and neural anomalies
- Tuberculosis Research and Epidemiology
- Advanced Chemical Sensor Technologies
- Maternal and fetal healthcare
- Electrochemical Analysis and Applications
- Infant Health and Development
- Cardiac Arrest and Resuscitation
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Trauma and Emergency Care Studies
- Hemodynamic Monitoring and Therapy
University of Manchester
2014-2018
Manchester Royal Infirmary
2018
Universidad Peruana Cayetano Heredia
2018
St Mary's Hospital
2015
Manchester Academic Health Science Centre
2015
Objective Currently, no investigations reliably identify placental dysfunction in late pregnancy. To facilitate the development of such we aimed to features that differ between normal and adverse outcome pregnancy a group pregnancies with reduced fetal movement. Methods Following third trimester presentation movement (N = 100), structure ex vivo was measured. Placental function then assessed terms (i) chorionic plate artery agonist responses length-tension characteristics using wire...
Irritable bowel syndrome (IBS) is traditionally divided into subtypes depending on the habit abnormality, but there little clarity in literature about whether these differ symptomatically or psychologically. Furthermore, are conflicting reports relationship between symptom severity and psychological status. The aim of this study was to address issues a large cohort patients defined by habit.One thousand IBS were diarrhea (IBS-D), constipation (IBS-C), mixed (IBS-M) completed series validated...
Introduction: Tuberculosis (TB) is a significant cause of morbidity and mortality worldwide. The patient compliance with the long treatment regimens essential for successful eradication. Pyrazinamide (PZA) shortens these from 9 to 6 months, therefore, improves completion rates. Although PZA first-line medication TB, no simple or reliable assay determine resistance yet available. In presence PZA, only susceptible Mycobacterium tuberculosis strains release pyrazinoic acid (POA). Therefore,...